Too Common to Ignore: Decoding the Complexity of the FGG p.Ala108Gly Variant in Fibrinogen Disorders.

Area of Science:

• Hematology
• Genetics
• Molecular Biology

Background:

• Congenital fibrinogen deficiencies are rare bleeding disorders.
• The FGG p.Ala108Gly variant is common and suggested by GWAS to lower fibrinogen levels.
• The clinical significance of the FGG p.Ala108Gly variant is debated.

Purpose of the Study:

• To review the clinical significance of the FGG p.Ala108Gly variant in congenital fibrinogen disorders.
• To analyze genotype-phenotype correlations for individuals with the FGG p.Ala108Gly variant.
• To highlight the need for further research into this common variant.

Main Methods:

• Literature review of case reports and existing studies.
• Analysis of genotype-phenotype data related to the FGG p.Ala108Gly variant.
• Commentary on the clinical implications of the variant.

Main Results:

• Most heterozygous carriers of FGG p.Ala108Gly exhibit normal fibrinogen levels.
• Hypofibrinogenemia is primarily observed in individuals with additional fibrinogen gene alterations.
• Some carriers with normal fibrinogen levels present with bleeding symptoms, suggesting genotype-phenotype discrepancies.

Conclusions:

• The FGG p.Ala108Gly variant presents clinical complexity.
• Its high prevalence necessitates further case-based studies to clarify its role in congenital fibrinogen disorders.
• Defining the clinical relevance of this variant requires more evidence.